icer glp-1 Incremental cost-effectiveness ratio (ICER) scatterplot comparing newer Weight-loss drugs becoming better value
Description
doi: 10.1053/meta.2001.24192
Lehrke M, Marx N, Patel S, et al
10.1016/j.jhep.2011.11.009 122 SanyalA
Moreover, this enhanced secretion could be suppressed by exogenous growth inhibitors
